Key result
Decreased 6-9 Hz cortical power identifies mechanical hyperalgesia in neuropathic pain rats with 0.77 AUC.
Why the study?
Neural biomarkers of chronic pain are needed to improve diagnosis speed and treatment delivery for chronic pain states.
Does power in the 6-9 Hz bandwidth of ECoG correlate with the development of chronic pain in rats?
Does power in the 6-9 Hz bandwidth of ECoG correlate with the development of chronic pain in rats?
Effect estimate: AUC 0.77
p-value: p=<0.05
Cortical 6-9 Hz oscillations, when compared to individual pre-injury baselines, serve as a reliable biomarker for identifying the presence of chronic pain in a rat model.
Provides a candidate biomarker for neuropathic pain in rats; leaves open translation to human chronic pain.
Neural biomarkers of chronic pain offer a potential tool for improving the speed of diagnosis and delivery of treatment for this devastating disease. Here, we tested the hypothesis that pain states are associated with distinct changed in cortical brain waves. We induced neuropathic orofacial pain in female rats by chronic constriction injury of the infraorbital nerve (CCI-ION). In most animals, this resulted in lasting reductions in mechanical sensitivity thresholds, and in lasting increases in facial grimace scores. We recorded electrocortigraphy (ECoG) signals over the neocortex of these rats, before and after CCI-ION, and analyzed these signals with a novel, spectral modelling approach. Consistent with our hypothesis, power in the 6-9 Hz bandwidth of the ECoG was differentially modulated in animals displaying signs of chronic pain. Specifically, development of mechanical hypersensitivity correlated with a decrease in 6-9 Hz power. Furthermore, we show that changes in the power of this oscillation after injury, obtained at the individual animal level, provide a more sensitive marker of pain presence than do traditional between animal comparisons of post-injury oscillatory power. Identification of animals demonstrating chronic-pain behaviors was more accurate when estimates of post-injury oscillatory power were compared against each animal’s own pre-injury baseline than when compared against post-injury power estimates from animals not developing chronic pain. These results highlight the need for establishing individual-specific, “pain-free” baselines from which oscillation disturbances can be measured and which may constitute a reliable, low-cost approach not only for diagnosing chronic pain, but also for identifying individuals likely to transition from acute to chronic pain.
No takes yet. Share an insight, caveat, or question.
Furman et al. (2020) studied Neuropathic orofacial pain (n=13). Chronic constriction injury of the infraorbital nerve (CCI-ION) vs. Pre-injury baseline and non-responder animals was evaluated on Accuracy of 6-9 Hz power change (Day 21 - Baseline) in classifying hyperalgesic vs. non-responder animals (AUC 0.77, p=<0.05). In a rat model of neuropathic pain, decreases in 6-9 Hz cortical oscillatory power from baseline accurately identified animals with mechanical hyperalgesia (AUC 0.77).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: